Alizadeh SD, et al
Telephone numbers of certified Poison Control Centers are listed in the Physicians' Desk Reference (PDR).* The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected
Unfortunately, some of these compounded versions were improperly prepared, mislabeled, or lacked FDA approval, creating serious health risks for patients
For employer-sponsored self-insured plans, you may also have the option to request an independent external review
Shannon Battle (08:49): Thats the hardest part of vetting knowing if companies truly follow the guidelines and compliance requirements
Lipid peroxidations byproducts, such as 4-hydroxynonenal or malondialdehyde, can react with lysine amino groups, histidine imidazole groups, or cysteine sulphydryl groups to damage proteins (153)